Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Niraparib With Abiraterone Acetate Plus Prednisone as First‐Line Therapy in Patients With Metastatic Castration‐Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study

PaperCitations, authors & open-access status

Niraparib With Abiraterone Acetate Plus Prednisone as First‐Line Therapy in Patients With Metastatic Castration‐Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1 citations, 2026 year and closed oa status.

1
Citations
2026
Year
closed
OA Status

Related on ScholarIQ

Anildeep Singh
Author
Prostate Cancer Treatment and Research
Topic
Prostate Cancer Treatment and Research
Topic
PARP inhibition in cancer therapy
Topic
Prostate Cancer Diagnosis and Treatment
Topic
470M+ articles · free account